Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with ...

Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® ...

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

Quest Diagnostics Incorporated (DGX), headquartered in Secaucus, New Jersey, offers diagnostic testing and services globally.

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

Quest Diagnostics Incorporated provides diagnostic testing and services in the United ... and accountable care organizations through a network of laboratories, patient service centers ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.